Transdermal GFR Assessment at the Point of Care
9:00 am - Wednesday 19th August 2026
- Overview of the TGFR™ System including review of the 2nd generation transdermal GFR methodology, indication for use, and patient care path
- Retrospective analysis of measured GFR (relmapirazin) and transdermal GFR data as it compares to current clinical practice
- Clinical use cases including a description of the unmet medical need and anticipated TGFR study design in specific patient sub-populations
- Future TGFR™ Developments